The following is a summary of “Enhanced anticancer efficacy of oxaliplatin-loaded PEGylated niosomes in breast cancer treatment,” published in the April 2025 issue of Cancer Nanotechnology by Moghaddam et al. Breast cancer continues to be one of the most commonly diagnosed malignancies among women worldwide, necessitating the development of more effective and targeted therapeutic strategies. […]
The post PEGylated Niosomal Oxaliplatin Enhances Antitumor Breast Therapy first appeared on Physician’s Weekly.
